Literature DB >> 33119547

Sustained cellular immune dysregulation in individuals recovering from SARS-CoV-2 infection.

Jacob K Files1, Sushma Boppana1, Mildred D Perez1, Sanghita Sarkar1, Kelsey E Lowman1, Kai Qin1, Sarah Sterrett1, Eric Carlin1, Anju Bansal1, Steffanie Sabbaj1, Dustin M Long2, Olaf Kutsch1,3, James Kobie1, Paul A Goepfert1,3, Nathan Erdmann1.   

Abstract

SARS-CoV-2 causes a wide spectrum of clinical manifestations and significant mortality. Studies investigating underlying immune characteristics are needed to understand disease pathogenesis and inform vaccine design. In this study, we examined immune cell subsets in hospitalized and nonhospitalized individuals. In hospitalized patients, many adaptive and innate immune cells were decreased in frequency compared with those of healthy and convalescent individuals, with the exception of an increase in B lymphocytes. Our findings show increased frequencies of T cell activation markers (CD69, OX40, HLA-DR, and CD154) in hospitalized patients, with other T cell activation/exhaustion markers (PD-L1 and TIGIT) remaining elevated in hospitalized and nonhospitalized individuals. B cells had a similar pattern of activation/exhaustion, with increased frequency of CD69 and CD95 during hospitalization followed by an increase in PD1 frequencies in nonhospitalized individuals. Interestingly, many of these changes were found to increase over time in nonhospitalized longitudinal samples, suggesting a prolonged period of immune dysregulation after SARS-CoV-2 infection. Changes in T cell activation/exhaustion in nonhospitalized patients were found to positively correlate with age. Severely infected individuals had increased expression of activation and exhaustion markers. These data suggest a prolonged period of immune dysregulation after SARS-CoV-2 infection, highlighting the need for additional studies investigating immune dysregulation in convalescent individuals.

Entities:  

Keywords:  COVID-19; Cellular immune response; Immunology

Mesh:

Substances:

Year:  2021        PMID: 33119547      PMCID: PMC7773371          DOI: 10.1172/JCI140491

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  55 in total

1.  Severe Influenza Is Characterized by Prolonged Immune Activation: Results From the SHIVERS Cohort Study.

Authors:  Sook-San Wong; Christine M Oshansky; Xi-Zhi J Guo; Jacqui Ralston; Timothy Wood; Ruth Seeds; Claire Newbern; Ben Waite; Gary Reynolds; Marc-Alain Widdowson; Q Sue Huang; Richard J Webby; Paul G Thomas
Journal:  J Infect Dis       Date:  2018-01-04       Impact factor: 5.226

2.  Response of memory CD8+ T cells to severe acute respiratory syndrome (SARS) coronavirus in recovered SARS patients and healthy individuals.

Authors:  Huabiao Chen; Jinlin Hou; Xiaodong Jiang; Shiwu Ma; Minjie Meng; Baomei Wang; Minghui Zhang; Mingxia Zhang; Xiaoping Tang; Fuchun Zhang; Tao Wan; Nan Li; Yizhi Yu; Hongbo Hu; Ruifu Yang; Wei He; Xiaoning Wang; Xuetao Cao
Journal:  J Immunol       Date:  2005-07-01       Impact factor: 5.422

3.  Analysis of serum cytokines in patients with severe acute respiratory syndrome.

Authors:  Yuanchun Zhang; Jing Li; Yuliang Zhan; Lianqiu Wu; Xueying Yu; Wenjian Zhang; Liya Ye; Shiqing Xu; Ruihua Sun; Yunting Wang; Jinning Lou
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

4.  Virological assessment of hospitalized patients with COVID-2019.

Authors:  Roman Wölfel; Victor M Corman; Wolfgang Guggemos; Michael Seilmaier; Sabine Zange; Marcel A Müller; Daniela Niemeyer; Terry C Jones; Patrick Vollmar; Camilla Rothe; Michael Hoelscher; Tobias Bleicker; Sebastian Brünink; Julia Schneider; Rosina Ehmann; Katrin Zwirglmaier; Christian Drosten; Clemens Wendtner
Journal:  Nature       Date:  2020-04-01       Impact factor: 49.962

5.  Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors.

Authors:  Alexandra-Chloé Villani; Rahul Satija; Gary Reynolds; Siranush Sarkizova; Karthik Shekhar; James Fletcher; Morgane Griesbeck; Andrew Butler; Shiwei Zheng; Suzan Lazo; Laura Jardine; David Dixon; Emily Stephenson; Emil Nilsson; Ida Grundberg; David McDonald; Andrew Filby; Weibo Li; Philip L De Jager; Orit Rozenblatt-Rosen; Andrew A Lane; Muzlifah Haniffa; Aviv Regev; Nir Hacohen
Journal:  Science       Date:  2017-04-21       Impact factor: 47.728

6.  Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications.

Authors:  Divij Mathew; Josephine R Giles; Amy E Baxter; Derek A Oldridge; Allison R Greenplate; Jennifer E Wu; Cécile Alanio; Leticia Kuri-Cervantes; M Betina Pampena; Kurt D'Andrea; Sasikanth Manne; Zeyu Chen; Yinghui Jane Huang; John P Reilly; Ariel R Weisman; Caroline A G Ittner; Oliva Kuthuru; Jeanette Dougherty; Kito Nzingha; Nicholas Han; Justin Kim; Ajinkya Pattekar; Eileen C Goodwin; Elizabeth M Anderson; Madison E Weirick; Sigrid Gouma; Claudia P Arevalo; Marcus J Bolton; Fang Chen; Simon F Lacey; Holly Ramage; Sara Cherry; Scott E Hensley; Sokratis A Apostolidis; Alexander C Huang; Laura A Vella; Michael R Betts; Nuala J Meyer; E John Wherry
Journal:  Science       Date:  2020-07-15       Impact factor: 47.728

7.  Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.

Authors:  Nanshan Chen; Min Zhou; Xuan Dong; Jieming Qu; Fengyun Gong; Yang Han; Yang Qiu; Jingli Wang; Ying Liu; Yuan Wei; Jia'an Xia; Ting Yu; Xinxin Zhang; Li Zhang
Journal:  Lancet       Date:  2020-01-30       Impact factor: 79.321

8.  Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study.

Authors:  Abdullah Assiri; Jaffar A Al-Tawfiq; Abdullah A Al-Rabeeah; Fahad A Al-Rabiah; Sami Al-Hajjar; Ali Al-Barrak; Hesham Flemban; Wafa N Al-Nassir; Hanan H Balkhy; Rafat F Al-Hakeem; Hatem Q Makhdoom; Alimuddin I Zumla; Ziad A Memish
Journal:  Lancet Infect Dis       Date:  2013-07-26       Impact factor: 25.071

Review 9.  The Role of PD-1 in Acute and Chronic Infection.

Authors:  Jil M Jubel; Zachary R Barbati; Christof Burger; Dieter C Wirtz; Frank A Schildberg
Journal:  Front Immunol       Date:  2020-03-24       Impact factor: 7.561

10.  Functional exhaustion of antiviral lymphocytes in COVID-19 patients.

Authors:  Meijuan Zheng; Yong Gao; Gang Wang; Guobin Song; Siyu Liu; Dandan Sun; Yuanhong Xu; Zhigang Tian
Journal:  Cell Mol Immunol       Date:  2020-03-19       Impact factor: 11.530

View more
  34 in total

Review 1.  Inhibitory immune checkpoint molecules and exhaustion of T cells in COVID-19.

Authors:  M Barnova; A Bobcakova; V Urdova; R Kosturiak; L Kapustova; D Dobrota; M Jesenak
Journal:  Physiol Res       Date:  2021-12-16       Impact factor: 1.881

2.  Chemokines, soluble PD-L1, and immune cell hyporesponsiveness are distinct features of SARS-CoV-2 critical illness.

Authors:  Eric D Morrell; Pavan K Bhatraju; Neha A Sathe; Jonathan Lawson; Linzee Mabrey; Sarah E Holton; Scott R Presnell; Alice Wiedeman; Carolina Acosta-Vega; Mallorie A Mitchem; Ted Liu; Xin-Ya Chai; Sharon Sahi; Carolyn Brager; Marika Orlov; Sana S Sakr; Anthony Sader; Dawn M Lum; Neall Koetje; Ashley Garay; Elizabeth Barnes; Gail Cromer; Mary K Bray; Sudhakar Pipavath; Susan L Fink; Laura Evans; S Alice Long; T Eoin West; Mark M Wurfel; Carmen Mikacenic
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2022-05-24       Impact factor: 6.011

3.  Glycosylation of Siglec15 promotes immunoescape and tumor growth.

Authors:  Yun-Long Wang; Ming-Biao Wei; Wan-Wen Zhao; Li-Li Feng; Xin-Ke Yin; Shao-Mei Bai; Xiang-Bo Wan; Mien-Chie Hung; Andrew Z Zou; Michael H Wang; Jian Zheng; Caolitao Qin; Xin-Juan Fan
Journal:  Am J Cancer Res       Date:  2021-05-15       Impact factor: 6.166

4.  Longitudinal Analysis of COVID-19 Patients Shows Age-Associated T Cell Changes Independent of Ongoing Ill-Health.

Authors:  Liam Townsend; Adam H Dyer; Aifric Naughton; Rachel Kiersey; Dean Holden; Mary Gardiner; Joanne Dowds; Kate O'Brien; Ciaran Bannan; Parthiban Nadarajan; Jean Dunne; Ignacio Martin-Loeches; Padraic G Fallon; Colm Bergin; Cliona O'Farrelly; Cliona Ni Cheallaigh; Nollaig M Bourke; Niall Conlon
Journal:  Front Immunol       Date:  2021-05-07       Impact factor: 7.561

5.  Post-surgical pyoderma gangrenosum in otherwise healthy patient with history of COVID-19.

Authors:  Matthew D Rich; Thomas J Sorenson; Warren Schubert
Journal:  Breast J       Date:  2021-05-24       Impact factor: 2.269

6.  Inefficient Placental Virus Replication and Absence of Neonatal Cell-Specific Immunity Upon Sars-CoV-2 Infection During Pregnancy.

Authors:  Ann-Christin Tallarek; Christopher Urbschat; Luis Fonseca Brito; Stephanie Stanelle-Bertram; Susanne Krasemann; Giada Frascaroli; Kristin Thiele; Agnes Wieczorek; Nadine Felber; Marc Lütgehetmann; Udo R Markert; Kurt Hecher; Wolfram Brune; Felix Stahl; Gülsah Gabriel; Anke Diemert; Petra Clara Arck
Journal:  Front Immunol       Date:  2021-06-03       Impact factor: 7.561

Review 7.  The Role of Immunogenetics in COVID-19.

Authors:  Fanny Pojero; Giuseppina Candore; Calogero Caruso; Danilo Di Bona; David A Groneberg; Mattia E Ligotti; Giulia Accardi; Anna Aiello
Journal:  Int J Mol Sci       Date:  2021-03-05       Impact factor: 5.923

8.  SARS-CoV-2-specific circulating T follicular helper cells correlate with neutralizing antibodies and increase during early convalescence.

Authors:  Sushma Boppana; Kai Qin; Jacob K Files; Ronnie M Russell; Regina Stoltz; Frederic Bibollet-Ruche; Anju Bansal; Nathan Erdmann; Beatrice H Hahn; Paul A Goepfert
Journal:  PLoS Pathog       Date:  2021-07-16       Impact factor: 6.823

9.  Comprehensive Immunologic Evaluation of Bronchoalveolar Lavage Samples from Human Patients with Moderate and Severe Seasonal Influenza and Severe COVID-19.

Authors:  Daniel Reynolds; Cristina Vazquez Guillamet; Aaron Day; Nicholas Borcherding; Rodrigo Vazquez Guillamet; José Alberto Choreño-Parra; Stacey L House; Jane A O'Halloran; Joaquín Zúñiga; Ali H Ellebedy; Derek E Byers; Philip A Mudd
Journal:  J Immunol       Date:  2021-08-04       Impact factor: 5.426

10.  Prolonged adaptive immune activation in COVID-19: implications for maintenance of long-term immunity?

Authors:  Philip A Mudd; Kenneth E Remy
Journal:  J Clin Invest       Date:  2021-01-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.